Browsing by Author "Gökdemir, Gül Şahika"

Now showing 1 - 15 of 15

Citation - WoS: 0
Citation - Scopus: 0
Assessment of Iron Metabolism and Inflammation in Children With Cerebral Palsy
(Mdpi, 2025) Orhan, Özhan; Gökdemir, Gül Şahika; Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Background/Objectives: Cerebral palsy (CP) is a motor disorder resulting from brain damage that is common in childhood. Iron is vital for the body's basic functions. Iron metabolism disorders and inflammation contribute to the neurological complications seen in CP. The purpose of this research was to ascertain the association and correlation between markers of inflammation and iron metabolism in children with CP. Methods: A total of 181 children diagnosed with CP and 111 typically developing children were retrospectively included in the study. Demographic data, blood parameters, C-reactive protein, iron, total iron binding capacity, and inflammation markers were evaluated. Results: C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR) and systemic immuno-inflammatory index (SII) levels of CP children were found to be statistically significantly higher than those of control group children (p < 0.05). Iron (Fe) and ferritin levels were lower in the CP group, while total iron binding capacity (TIBC) was higher. Spearman correlation analysis showed significant correlations between iron, ferritin and TIBC and SII. Conclusions: Iron deficiency and chronic inflammation are associated with the pathophysiology of CP in patients with CP, and therefore it is important to monitor markers of iron metabolism and inflammation in these patients.
Clınıcal Sıgnıfıcance of HDL-C Values And Routıne Parameters Of Inflammatıon Such As Hs-Crp, Lenfocyte And Neutrofıl Ratıos In Covıd-19 Patıents
(İZMİR ATATÜRK EĞİTİM HASTANESİ TIP DERGİSİ, 2023) Gökdemir, Gül Şahika; Nas, Cemal; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Objective: The study aimed to evaluate the prognostic significance of high-density lipoprotein cholesterol (HDL-C) levels, alongside markers including the neutrophil/HDL-C ratio (NHR) and lymphocyte/HDL-C ratio (LHR), on the mortality of COVID-19 patients. It also examined the potential clinical application of these biomarkers in the management of future healthcare crises, despite the end of the COVID-19 pandemic. Materials and Methods: Patients diagnosed with COVID-19 were retrospectively analysed between March 2020 and August 2022. A total of 367 patients were categorised into two groups: survivors (group 2) and non-survivors (group 1). Patient demographics, biochemical and haematological parameters obtained from blood samples, high-sensitivity C-reactive protein (hs-CRP), neutrophil-to-lymphocyte ratio (NLR), monocyte/HDL-C ratio (MHR), NHR, LHR, platelet/HDL-C ratio (PHR) were calculated. Patient data were analysed using SPSS 26 and statistical differences of P<0.05 were considered significant. Results: Among the patients analyzed in the study, the living group constituted 89.9% of individuals, while the deceased group represented 10.1%. The neutrophil levels were significantly higher in the deceased group, and NLR and NHR values were statistically significant (P<0.001 and P=0.001, respectively). There was no significant difference in HDL-C levels. Moreover, no significant differences in LHR, MHR, and PHR levels were observed between groups. The hs-CRP levels were significantly higher in the deceased (P<0.001). Correlation analysis indicated a negative correlation between HDL-C and LHR and NHR, and significant correlations were found for other markers. ROC analysis showed that LHR and NHR were significant in discriminating deceased patients. Conclusion: Biochemical and haematological parameters, especially markers such as NLR and NHR, can potentially be used to assess the risk of death in COVID-19 patients. These markers may be valuable in predicting the prognosis of patients and could be used in future similar health crises.
Citation - WoS: 0
Citation - Scopus: 0
The Effect of Acute Carbon Monoxide Intoxication on Cardiac Necrosis in Rats: in Relation To Adiponectin Levels
(Univ Zulia, Facultad Ciencias veterinarias, 2025) Gökdemir, Gül Şahika; Gökdemir, Mehmet Tahir; Demirtas, Berjan; Gokdemir, Mehmet Tahir; Sogut, Ozgur; Canpolat-Erkan, Revsa Evin; Yokus, Beran; Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
In order to investigate the effects of acute CO poisoning and subsequent oxygen therapy on cardiac necrosis in rats, with a specific focus on adiponectin levels, twenty-one male Wistar albino rats were divided into three groups (Control, CO, CO+O-2). The Control group was placed in a container and exposed to room air for 30 min. Acute CO poisoning was induced in the CO group and CO+O-2 group by exposing the rats to CO gas for 30 min. Following CO exposure, the CO+O-2 group received oxygen therapy for 30 min, while the CO group did not receive any additional intervention. The animals were euthanized by cardiac puncture under anesthesia, following the approved ethical procedures. Carboxyhemoglobin (COHb), serum levels of creatine kinase (CK), creatine kinase myocardial band (CK-MB), C-reactive protein (CRP) and lactate dehydrogenase (LDH), as well as cardiac and serum adiponectin levels were measured. CO poisoning caused necrosis in cardiac tissue however, oxygen therapy alleviated the negative effect of CO on cardiac injury. COHb and LDH levels in CO group were increased, whereas both cardiac and serum adiponectin levels were decreased (all, P<0.05). There were no changes in CK, CK-MB, CRP levels among groups (all, P>0.05). Oxygen therapy decreased COHb, but increased both cardiac and serum adiponectin levels (all, P<0.05). Adiponectin and LDH may serve as potential biomarkers for early diagnosis of cardiac necrosis caused by acute CO poisoning. The assessment or quantification of adiponectin can also be useful for the early prognosis of cardiac necrosis after oxygen therapy.
The Effect of Gliclazide use on BDNF and NGF Levels in Rats with Diabetes Mellitus
(2023) Gökdemir, Gül Şahika; Baylan,Mukadder; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Objective: In this study, the effects of gliclazides, a second generation sulfonylurea group, on BDNF and NGF plasma levels, which are considered neurodegeneration biomarkers, will be examined. When designing our study, we assumed that gliazides might have positive neuronal effects. Thus, the possible positive effects of gliclazide will be emphasized in our study. Methods: In the experiment, 21 adult male Wistar-Albino rats were used. Serum BDNF and NGF levels were determined by analyzing with enzyme-linked immunosorbent assay kit in accordance with the recommendations. Results: BDNF levels were significantly lower in gliclazide-treated diabetic rats and nonmedicated diabetic rats compared to the healthy control group (p=0.017, p<0.001, respectively). Although the BDNF level of rats with diabetes given gliclazide was increased compared to rats with and without diabetes, this difference was not significant (p=0.107). Similarly, NGF levels were significantly lower in rats given gliclazide (p=0.009) and diabetic rats not given gliclazide (p=0.001) compared to the healthy control group. When the diabetic groups were compared among themselves, although the NGF level was increased in the gliclazide group, this difference was not statistically significant (p=0.638). The differences between the groups were significant in cyclic AMP regulatory element binding (p<0.001), c-FOS (p<0.001), amyloid precursor protein (p<0.001), B-SECRETASE1 (p=0.004), and doublecortin (p<0.001) levels. Conclusion: As a result, serum BDNF and NGF levels were significantly higher in non-diabetic healthy control group rats than in diabetic rats. While low serum levels of BDNF and NGF neurotrophins, which increase in neurodegeneration, were observed in diabetic rats, this level was observed to be higher in diabetic rats given gliclazide.
EFFECT OF METFORMIN ON MUSCLE ATROPHY IN EXPERIMENTAL DIABETIC RATS
(2023) Gökdemir, Gül Şahika; Gökdemir, Mehmet Tahir; Gökdemir, Mehmet Tahir; Baylan,Mukadder; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü; Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü
Background: Although first-line biguanide metformin is frequently administered to T2DM patients, the effects of long-term use on muscle are unknown. This study aimed to examine the effect of metformin-treated diabetes on muscle atrophy in experimental diabetic rats. Materials and methods: Twenty-one Wistar albino male rats in 3 groups were included in our research. Insulin resistance HOMA-IR, mTOR, and Myostatin levels and gastrocnemius weight were measured. Results: Myostatin level was significantly higher in the non-medicated diabetes group than in the healthy control group (p<0.001). Moreover, myostatin level was significantly lower in the metformin group (p=0.001). The weight of gastrocnemius was significantly lower in both the metformin-treated and non-metformin-treated diabetic groups compared to the control group (p<0.001 for both groups). Moreover, the gastrocnemius weight was significantly higher in the metformin group than in the non-medicated group (p=0.004). The HOME-IR level had a significantly negative correlation with the mTOR level (R=-0.783; P<0.001) and a positive correlation with the myostatin level (R=0.622; P=0.003). Conclusion: Our evidence and data support that metformin may be effective in preventing muscle wasting. To conclude, this study showed that metformin has anti-atrophic effects on muscles in diabetes and that metformin can prevent muscle mass loss.
Citation - WoS: 1
Citation - Scopus: 1
Effects of acute carbon monoxide posioning on liver damage and comparisons of related oxygen therapies in a rat model
(Taylor & Francis Ltd, 2024) Gökdemir, Gül Şahika; Gokdemir, Gul Sahika; Seker, Ugur; Şeker, Uğur; Demirtas, Berjan; Taskin, Seyhan; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Acute carbon monoxide (CO) poisoning may cause liver damage and liver dysfunction. Therefore, in this study, we aimed to compare the efficiency of normobaric oxygen (NBO) and high-flow nasal cannula oxygen (HFNCO) treatments on liver injury. For that purpose, 28 male Wistar albino rats were divided into four groups (Control, CO, CO + NBO, and CO + HFNCO). The control group was allowed to breath room air for 30 min. Acute CO poisoning in CO, CO + NBO, CO + HFNCO was induced by CO exposure for 30 min. Thereafter, NBO group received 100% NBO with reservoir mask for 30 min. HFNCO group received high-flow oxygen through nasal cannula for 30 min. At the end of the experiment, all animals were sacrificed by cardiac puncture under anesthesia. Serum liver function tests were measured. Liver tissue total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) levels, tissue histomorphology and immunoexpression levels of Bax, Caspase 3, TNF-alpha, IL-1 beta, and NF-kappa B were also examined. Our observations indicated that acute CO poisoning caused significant increases in blood COHb, serum aminotransferase (AST), alanine aminotransferase (ALT0, alkaline phosphatase (ALP), total protein, albumin, and globulin levels but a decrease in albumin to globulin ratio (all, p < 0.05). Furthermore, acute CO poisoning significantly increased the OSI value, and the immunoexpresssion of Bax, Caspase 3, TNF-alpha, IL-1 beta, and NF-kappa B in liver tissue (all, p < 0.05). These pathological changes in serum and liver tissue were alleviated through both of the treatment methods. In conclusion, both the NBO and HFNCO treatments were beneficial to alleviate the acute CO poisoning associated with liver injury and dysfunction. [GRAPHICS] .
Endokrin Sistem Fizyolojisi
(Akademisyen Kitapevi, 2023) Gökdemir, Gül Şahika; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Endokrin Sistem Fizyolojisi
Citation - WoS: 1
Citation - Scopus: 1
Evaluation of the pleth variability index, perfusion index, and other physiological parameters after COVID-19
(Verduci Editore srl, 2023) Gökdemir, Gül Şahika; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Objective: The aim of this study was to observe the changes in pleth variability index (PVI), perfusion index (PI) and other hemodynamic parameters in adult individuals who had had Coronavirus disease 2019 (COVID-19) and were currently living a normal life. A further aim was to draw attention to the fact that some hemodynamic changes after COVID-19 may cause long-term health problems. Patients and methods: A total of 174 adult individuals who had had COVID-19 and were currently living a normal life and 56 healthy individuals with similar demographic characteristics who had not had COVID-19 were included in the study. The PI, PVI, oxygen saturation (SpO2), pulse rate (PR), total hemoglobin (Hgb), oxygen reserve index (ORI), and blood pressure values were measured by Masimo Radical 7. The data of individuals who had and did not have COVID-19 before were compared. Results: The mean PVI (p = 0.008) and PI (p < 0.001) were significantly lower in people who had been exposed to COVID-19. Likewise, the mean of ORI, SpO2, and SpOC values was observed to be significantly lower in participants exposed to COVID-19 disease (p < 0.001, p < 0.001, and p = 0.006, respectively). The PVI had a positive correlation with body mass index (BMI) (r = 0.263, p < 0.001) and a negative correlation with SpO2 (r = -0.194, p = 0.003) and PR (r = 0.190, p = 0.004). Conclusions: The PVI, PI, and other physiological parameters could potentially be useful for monitoring COVID-19 patients and evaluating their response to therapy. We believe that people who have been exposed to COVID-19 may be more susceptible to other diseases; therefore, they should be subjected to regular clinical checks.
Hastaneye İskemik İnme ile Başvuran Geriatrik Hastalarda Ortalama Trombosit Hacmi/trombosit, Nötrofil/lökosit Oranı ve Troponin Değerlerinin Araştırılması
(2024) Gökdemir, Gül Şahika; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Amaç: Bu çalışmanın amacı, iskemik inme ile hastaneye başvuran geriatrik hastalarda ortalama MPV/PLT oranı, NLR ve troponin I düzeylerini araştırmak ve bu parametrelerin prognostik değerlerini değerlendirmektir. Bu şekilde, iskemik inme hastalarının değerlendirme ve tedavi süreçlerinde daha iyi bir klinik karar verme sağlanabilir. Yöntem: Geriye dönük bir tasarım kullanılarak, iskemik inme tanısıyla hastaneye başvuran geriatrik hastaların verileri retrospektif olarak incelendi. Hastaların demografik özellikleri, klinik bulguları, laboratuvar sonuçları ve radyolojik bulguları elektronik tıbbi kayıtlardan elde edildi. Trombosit hacmi, platelet sayısı, nötrofil sayısı, lökosit sayısı ve troponin I düzeyleri primer veriler, diğer demografik, klinik ve laboratuvar parametreleri de ikincil veriler olarak kaydedildi. Bulgular: MPV/PLT oranı, iskemik inme hastalarında (0,04±0,02) iskemik inme olmayan hastalara (0,03±0,02) göre anlamlı oranda daha yüksek olarak gözlemlendi (p<0,001). Benzer olarak iskemik inme hastalarında NLR (5,29±5,09), diğer gruba oranla (1,93±0,87) anlamlı oranda daha yüksek idi (p<0,001). Buna ek olarak Troponin I düzeyi, iskemik inme hastalarında (10,48±7,88 ng/mL) diğer gruptan (2,18±1,11 ng/mL) bariz olarak yüksek idi (p<0,001). Sonuç: Bu çalışma, iskemik inme ile hastaneye başvuran geriatrik hastalarda ortalama MPV/PLT oranı, NLR ve troponin I düzeylerinin prognostik değerlerini ortaya koymaktadır. Bu parametrelerin klinik değerlendirmelerde kullanılması, iskemik inme hastalarının takibinde ve tedavi stratejilerinin belirlenmesinde yardımcı olabilir.
Importance of Curcumin Effect and Asprosin Level on Glucose Metabolism in Diabetic Rats
(2023) Gökdemir, Gül Şahika; Atmaca, Mukadder; Gokdemir, Gul Sahika; Gökdemir, Mehmet Tahir; Gökdemir, Mehmet Tahir; Taşdemir, Ezel; Yokus, Beran; Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Asprosin is a new hormone secreted mainly from white adipose tissue. It may be associated with the pathogenesis of obesity, diabetes and some metabolic diseases. The changes in plasma asprosin levels of experimental diabetic rats and the relation of these changes with liver glucose metabolism and some diabetes parameters were investigated, and the effects of metformin, gliclazide or curcumin treatment on plasma asprosin levels were tried. The study was designed as an animal model in diabetic rats The albino rats were divided into five groups. To induce diabetes, a single dose of STZ was injected intraperitoneally. Diabetics rats were treated intragastrically with metformin (D+Metformin group), gliclazide (D+Giliclazide group) or 20 curcumin (D+Curcumin group) for eight weeks. Fasting blood glucose, insulin levels and other parameters were measured. Plasma asporsin levels of untreated diabetic rats increased significantly (P<.001). Although the plasma asprosin levels of diabetic rats treated with the rugs were significantly lower (P<.001). Fasting blood glucose levels of diabetic rats treated with the drugs were found to be remarkably lower than the diabetic control values (P<.001, respectively). There was no significant difference in the insulin levels and HOMA- IR between these three groups. Curcumin treatment provides significant improvements in plasma asprosin level and diabetes parameters. The increase in plasma asprosin level in diabetic rats may be one of the main reasons that facilitate the development of the disease or is responsible for its pathogenesis. Our findings support the idea that curcumin may be an important treatment option for diabetes.
Citation - WoS: 0
The Importance of Serum Vitamin B12, Folic Acid and Ferritin Levels in Acute Ischemic Stroke Patients
(Wiley, 2023) Gökdemir, Gül Şahika; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
[No Abstract Available]
Citation - WoS: 0
Citation - Scopus: 0
Investigation of the Relationship Between Plasma Ghrelin Levels and Muscle Atrophy in Experimental Diabetic Rats
(Polska Akad Nauk, Polish Acad Sciences, Univ Warmia & Mazury Olsztyn, 2024) Gökdemir, Gül Şahika; Koç Direk, Figen; Asir, F.; Kaya, H. Kayhan; Diken, H.; Gokdemir, G. S.; Direk, F. Koc; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
In this study, the relationship between plasma ghrelin levels and muscle atrophy was examined in an experimental diabetic rat model. 56 male Wistar albino rats, aged 8-10 weeks, were used in the study. The rats were divided into 8 groupsD1: one -week diabetes, C1: one -week control, D2: three-week diabetes, C2: three-week control, D3: six -week diabetes, C3: six -week control, D4: eight -week diabetes, C4: eight -week control. To induce diabetes, rats were injected with a single intraperitoneal dose of 45 mg/kg streptozotocin. At the end of the experiments, body weights and fasting blood sugar levels were measured. mTOR and myostatin levels of gastrocnemius muscle and plasma ghrelin levels were measured by ELISA method. Gastrocnemius muscle weight, cross-sectional area and histopathological images were examined. It was observed that the gastrocnemius weights of the D2, D3, D4 groups decreased significantly compared to their controls (p <= 0.01). Muscle cross-sectional area decreased significantly in groups D3 and D4 compared to controls (p <= 0.01). Muscle mTOR levels were found to be significantly lower in all diabetic groups compared to controls (p <= 0.01). Although muscle myostatin levels were higher in the diabetic groups, this increase was only significant in the D4 group. Plasma ghrelin levels were significantly lower in all diabetic groups compared to controls (p <= 0.01). A positive correlation was determined between plasma ghrelin levels and the final weights, muscle cross-sectional area, gastrocnemius weights and mTOR levels of the rats. Time -dependent muscle atrophy developed in diabetic rats and there was a relationship between muscle atrophy and plasma ghrelin level. We suggest that ghrelin plays a role in diabetes -induced muscle atrophy as well as cachexia and sarcopenia.
Citation - WoS: 0
Citation - Scopus: 0
The M1/M2 Macrophage Polarization and Hepatoprotective Activity of Quercetin in Cyclophosphamide-Induced Experimental Liver Toxicity
(Wiley, 2025) Şeker, Uğur; Gökdemir, Gül Şahika; Gokdemir, Gul Sahika; Kavak, Deniz Evrim; Irtegun-Kandemir, Sevgi; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Background: Chemotherapy drugs may lead to hepatic injury, which is considered one of the limitations of these drugs. Objectives: The aim of this study was to evaluate the effect of quercetin (QUE) on M1/M2 macrophage polarization and hepatoprotective effect in cyclophosphamide (CTX)-induced liver toxicity. Methods: Twenty-four mice were divided into four groups (Control, QUE, CTX, CTX + QUE). The CTX and CTX + QUE groups received 200 mg/kg CTX. The animals in the QUE and CTX + QUE groups received 50 mg/kg QUE. All animals were sacrificed, and serum and liver samples were used for laboratory analyses. Results: Examinations indicated that CTX exposure led to disruption of liver functions and morphological degenerations. Tissue pro-apoptotic Bax and caspase 3, pro-inflammatory TNF-alpha and IL-1 beta, transcription factor NF-kappa B, and M1 macrophage polarization marker CD86 were upregulated significant (p < 0.05) in this group. In addition, CTX exposure led to significantly (p < 0.05) upregulation of the Bax/Bcl-2 mRNA ratio and DNA fragmentations. The PCNA-positive hepatic cell ratio and anti-apoptotic Bcl-2 expression are remarkably suppressed (p < 0.05). Immunohistochemical analyses are also indicated that M2 macrophage polarization marker CD163 is slightly but remarkably (p < 0.05) downregulated in the CTX group compared to the Control and QUE groups. The morphological and biochemical disruptions were alleviated in QUE-treated animals in the CTX + QUE group. Liver function test results, apoptosis, inflammatory, transcription factor NF-kappa B, regeneration/proliferation, and apoptotic index results in this group were similar (p > 0.05) to the control and QUE groups. The M1 cell surface marker expression of CD86 is significantly (p < 0.05) downregulated, and M2 macrophage polarization marker expression of CD163 is upregulated significantly (p < 0.05) compared to the CTX group. Conclusions: This study indicates that QUE has the potential to downregulate CTX-induced hepatic injury and regulate M1/M2 macrophage polarization to the M2 side, which indirectly demonstrates activation of anti-inflammatory signalling and tissue repair.
Citation - Scopus: 0
Physiopathology of allergic diseases and their relation to circadian rhythm
(Nova Science Publishers, Inc., 2024) Gökdemir, Gül Şahika; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Allergic diseases have become a major health problem in modern society. These diseases are caused by an overreaction of the immune system and are often triggered by exposure to environmental allergens. Allergic diseases include asthma, allergicrhinitis, eczema, food allergies, and anaphylaxis. In recent years, research on the effectof circadian rhythm on the immune system has shown that there is an important relationship between the pathophysiology of allergic diseases and circadian rhythm. The pathophysiology of allergic diseases begins with responses to the immune system and the effect of allergens. The immune system is a complex network that regulates the response of immune cells. Immunoglobulin E (IgE) antibodies play an important role inreactions of hypersensitivity to allergens. Exposure to allergens triggers the activation of mast cells and basophils, resulting in the release of inflammatory mediators. The circadian rhythm is an internal clock system that regulates the 24-hour cycle of biological processes. The human body adapts various physiological and metabolic processes to this rhythm. The relationship of allergic diseases with the circadian rhythmis related to their effects on both the immune system and tissue and organ function. The circulation and activity of immune cells can change depending on the circadian rhythm. These changes can influence the immune system's response to exposure to allergens. In addition, the symptoms and severity of allergic diseases are also related to the circadian rhythm. Some studies have shown that allergic symptoms increase at night or in the morning. This suggests that the circadian rhythm may influence the severity of allergic reactions by affecting the release of immunoglobulins, the inflammatory response, and bronchial hyperreactivity. This chapter aims to provide researchers, clinicians, and healthcare professionals with an important resource on recent research findings that advance our understanding of the relationship between the pathophysiology of allergic diseases and the relationship between circadian rhythm.
Citation - WoS: 1
Citation - Scopus: 1
Prognostic significance of the chemerin level in coronavirus disease 2019 patients
(Lippincott Williams & Wilkins, 2024) Gökdemir, Gül Şahika; Gokdemir, Guel Sahika; Gokdemir, Mehmet Tahir; Gökdemir, Mehmet Tahir; Arac, Songul; Yokus, Beran; Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü; Department of Basic Medical Sciences / Temel Tıp Bilimleri Bölümü
Increased serum chemerin levels have been reported in several inflammatory diseases. Few studies have investigated the relationship between chemerin and clinical features of COVID-19. Thus, chemerin may modulate the development and progression of COVID-19. We compared the serum chemerin concentration between patients with and without SARS-CoV-2 infection and its association with the severity and prognosis of COVID-19 pneumonia. This is a prospective, single-center, cross-sectional study. We enrolled COVID-19 patients who presented to our tertiary hospital and healthy controls. The COVID-19 patients were conducted and the dates of symptom onset were recorded. After admission to the hospital and stabilization, blood samples were obtained for routine hemogram, biochemistry, and chemerin. The chemerin level was 37.93 +/- 17.3 ng/mL in patients followed in the ICU, 29.41 +/- 12.79 ng/mL in inpatients, 30.48 +/- 10.86 ng/mL in outpatients, and 25.12 +/- 9.82 ng/mL in healthy controls. The difference between patients treated in the ICU and healthy controls was significant (P < .001). The high-sensitivity C-reactive protein (hs-CRP), ferritin, procalcitonin (PCT), and D-dimer levels were significantly higher in the intensive care unit (ICU) group (P < .001). Moreover, the chemerin level of patients who died was significantly higher than that of those who survived (P < .001). The chemerin level was increased in COVID-19 patients and also increased with increasing disease severity. The chemerin level was higher in the COVID-19 patients than healthy controls and was significantly higher in patients who died compared to those who did not.